28May

First multi-site installation of HORIBA Medical’s new HELO modular automated haematology platform

Horibalogo

Northampton, UK – 28th May 2019 – HORIBA UK Ltd, Medical announces the go live of the first multi-site installation of its new HELO high throughput fully automated haematology platform within the Cardiff and Vale University Health Board. The new system is already delivering laboratory efficiencies across Cardiff in line with NHS requirements through the next generation haematology analysers installed at the University Hospital of Wales (UHW) and University Hospital, Llandough. Both sites are fully UKAS accredited to ISO 15189 and networked together by a single virtual server to facilitate highly efficient and secure cross city working.

 

Cardiff upgraded across the city with four new HORIBA Yumizen tracked haematology analysers at UHW and two separate Yumizen analysers at Llandough, both sites have also installed a Slide Preparation System. Through the HELO platform all of these analysers are brought together into a single networked system where results can be remotely authorised. This single service, allowing remote management from one site to the other, has enabled the sites to skill-mix staff successfully and keep within a stringent financial framework.

 

Alun Roderick, Haematology, Blood Transfusion and Phlebotomy Service Manager, Cardiff and Vale University Health Board, said, “The efficiencies that HELO has allowed us is breath-taking. Samples are being processed quicker and we can be more efficient with the way that we deploy staff. Using support staff more and putting our qualified biomedical scientists exactly where they need to be at the right time. This means we can support more specialist laboratories, including blood transfusion, while maintaining the quality of our overall service, but just in a different way.”

 

“We are now able to provide our staff with a broader experience of the laboratory. Rather than just dealing with full blood counts as a factory, our qualified staff now also have the time to work in more interesting specialist areas, such as undertaking immunophenotyping, doing more haemoglobinopathies or specialist coagulation,” Alun added.

 

Using the new HELO platform with Yumizen analysers has allowed Cardiff to review the workflow coming through its laboratories. In addition to the efficiencies gained from having a single service across two sites by applying data management to maximum capacity, using the track-based system enables the analysers to perform optimally. The HELO system automatically disperses samples to the most appropriate analyser, as well as undertakes blood films for example using reflex rules.

 

Alun Roderick also observed the high level of support that HORIBA Medical gave throughout the installation process and beyond. “The installation plan was extremely smooth without disruption to the laboratory and the support offered has been first class. HORIBA worked with us in partnership every step of the way to produce all the vital validation and verification documentation, as well as the staff training with ongoing competencies needed for us to maintain our ISO 15189 accreditation.”

 

Mandy Campbell, HORIBA Medical, concluded, “This first multi-site installation of our new HELO modular haematology platform marks another successful step in our long-standing partnership with Cardiff. We are proud that they continue to recognise the quality of our products and support, and are delighted that we have been able to enable their evolving provision of service.”

 

For more information on HORIBA UK Ltd. Medical and its products, please visit: www.horiba.com/uk/medical.

Related

OGT makes market-leading NGS coverage and expertise more accessible

Oxford, UK – 13 June 2019. Oxford Gene Technology (OGT), The Molecular Genetics Company, has expand...

Read More >

BBI Solutions adds more antibodies to product range

BBI Solutions has continued to invest in its portfolio of antibodies and today announced the launch ...

Read More >

In Brief This Week: VolitionRx, Bio-Techne, Biocept, Meridian Bioscience, and More

NEW YORK (360Dx) – VolitionRx reported a second quarter net loss of $3.5 million, or $.13 per share...

Read More >

Evaluation studies confirm improved oncology patient pathways through HORIBA Medical’s new POC haematology analyser

Yumizen H500 full blood count analyser demonstrates exceptional correlation with larger laboratory-b...

Read More >

Radiometer sponsors World Sepsis Day 2017

In continuation of Radiometer’s commitment to the fight against sepsis – one of the world’s deadl...

Read More >

Biofortuna closes £1.6M funding round

Biofortuna Ltd, a UK-based diagnostics company offering molecular diagnostic products and contract m...

Read More >